Aromatherapy and VR enhance sleep quality in diabetes
This study investigated the effects of lavender aromatherapy and virtual reality on sleep quality in patients with type 2 diabetes, finding significant improvements in both interventions.
Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This study investigated the effects of lavender aromatherapy and virtual reality on sleep quality in patients with type 2 diabetes, finding significant improvements in both interventions.
Astaxanthin supplementation significantly reduced inflammation-related microRNAs and improved metabolic markers in type 2 diabetes patients.
This study investigated the effects of auricular acupressure on sleep quality and blood glucose levels in elderly individuals with type 2 diabetes, finding significant improvements in both areas.
This study evaluated the benefits of automated insulin delivery (AID) in adults with type 2 diabetes on GLP-1 receptor agonists, finding significant improvements in HbA1c and time-in-range.
This pilot study evaluated the Type 1 Diabetes and Life (T1DAL) intervention aimed at improving health-related quality of life in individuals with Type 1 diabetes.
This study evaluated the efficacy and safety of bi-weekly cofrogliptin compared to daily DPP-4 inhibitors in Chinese patients with Type 2 Diabetes Mellitus.
This study investigated the effects of long-term bilberry and grape seed extract supplementation on blood pressure in individuals at risk of type 2 diabetes mellitus (T2DM). It found significant reductions in systolic and diastolic blood pressure.
This study evaluated the efficacy and safety of Bifidobacterium longum subsp. longum BL21 as an adjunctive therapy to metformin in patients with type 2 diabetes, finding a significant reduction in HbA1c levels.
This study evaluated the effects of canagliflozin on cardiovascular and kidney outcomes in individuals with type 2 diabetes, finding a reduction in major adverse cardiovascular events.
This study evaluated the effects of canagliflozin combined with metformin on cardiovascular risk in patients with type 2 diabetes mellitus, finding a significant reduction in major adverse cardiovascular events.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.